Patent · US Expired

Hyperstabilizing antisense nucleic acid binding agents

US5786138A · kind A · utility

42Cited by
3References
47Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 11, 1994
Grant dateJul 28, 1998
Priority date
Expiry dateAug 11, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3511
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Attaching certain ligands to antisense probes will hyperstabilize sense-antisense duplexes. Such a hyperstabilized duplex is resistant to melting of the strands from one another, to unwinding of the strands, and to the action of nucleases. Applications include antiretroviral action, anti-reverse-transcriptase action, antiviral action, antiparasitical action, antibacterial action, antifungal action, anticancer action, anti-oncogene action, and other applications where it is desired to inhibit gene expression at the genomic or messenger RNA level. The preferred ligands are certain minor-groove-binding agents, exemplified by CC-1065 and synthetic CC-1065 analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.